The Brazilian Society of Rheumatology guidelines for axial spondyloarthritis - 2019
Resende, Gustavo Gomes; Meirelles, Eduardo de Souza; Marques, Cláudia Diniz Lopes; Chiereghin, Adriano; Lyrio, Andre Marun; Ximenes, Antônio Carlos; Saad, Carla Gonçalves; Gonçalves, Célio Roberto; Kohem, Charles Lubianca; Schainberg, Cláudia Goldenstein; Campanholo, Cristiano Barbosa; Bueno Filho, Júlio Silvio de Sousa; Pieruccetti, Lenise Brandao; Keiserman, Mauro Waldemar; Yazbek, Michel Alexandre; Palominos, Penelope Esther; Goncalves, Rafaela Silva Guimarães; Lage, Ricardo da Cruz; Assad, Rodrigo Luppino; Bonfiglioli, Rubens; Anti, Sônia Maria Alvarenga; Carneiro, Sueli; Oliveira, Thauana Luíza; Azevedo, Valderílio Feijó; Bianchi, Washington Alves; Bernardo, Wanderley Marques; Pinheiro, Marcelo de Medeiros; Sampaio-Barros, Percival Degrava.
Adv Rheumatol
; 60: 19, 2020. tab, graf
Artigo
em Inglês
| LILACS | ID: biblio-1088654
Abstract Spondyloarthritis is a group of chronic inflammatory systemic diseases characterized by axial and/or peripheral joints inflammation, as well as extra-articular manifestations. The classification axial spondyloarthritis is adopted when the spine and/or the sacroiliac joints are predominantly involved. This version of recommendations replaces the previous guidelines published in May 2013. A systematic literature review was performed, and two hundred thirty-seven studies were selected and used to formulate 29 recommendations answering 15 clinical questions, which were divided into four sections: diagnosis, non-pharmacological therapy, conventional drug therapy and biological therapy. For each recommendation the level of evidence supporting (highest available), the strength grade according to Oxford, and the degree of expert agreement (inter-rater reliability) is informed. These guidelines bring evidence-based information on clinical management of axial SpA patients, including, diagnosis, treatment, and prognosis.
Biblioteca responsável:
BR1.1
Texto completo
Documentos relacionados